MedTrace Logo

Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus

NCT04155996 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-04-11

No results posted yet for this study

Summary

The aim of this study is to collect continuous glucose monitoring (CGM) data, coupled with physical activity and everyday day life data. The purpose of this data collection is to help diabetologists to make recommendations to optimize type 2 diabetic patient management.

Conditions

  • Type2 Diabetes

Interventions

DEVICE

data collection

Patients will receive a full data acquisition set with CGM sensors, an activity tracker and a smartphone application in which they can log daily events.

Sponsors & Collaborators

  • APHP

    collaborator OTHER

  • ValoTec

    lead INDUSTRY

Principal Investigators

  • Marine HALBRON, MD · APHP

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-20
Primary Completion
2020-12-04
Completion
2020-12-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04155996 on ClinicalTrials.gov